Clinical Trial Update: Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prostaglandin inhibition combined with immune checkpoint blockade in melanoma; completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Stage Iiia Cutaneous Melanoma
• Stage Iiib Cutaneous Melanoma
• Stage Iiic Cutaneous Melanoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Stage III Cutaneous Melanoma, Stage IIIA Cutaneous Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-10